Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation
This article is from
The Cancer Letter
archive.
Vol. 37 No. 8 | August 29, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
DCT Board Says RDOG Concept Too Expensive; Discusses Grant Funding
July 24, 1992
TCL Archive
NCI-Approved Clinical Trials
August 25, 2006
TCL Archive
NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”
October 23, 1981
TCL Archive
Higgins: VA Groups D Have Review; NCI: It’s Ad Hoc
December 2, 1977
TCL Archive
NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.
April 20, 2007
TCL Archive
USC Opts for Its own IL-2 Protocol, Shuns NCI Trial
May 8, 1987